Tag: Biotech

CEO Sells 34K Shares of Biotech Stock, Valued at $615,000, According to Latest SEC Filing

Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares

Is This Millionaire-Maker Biotech Stock a Buy Right Now?

From drought to demand: Biotech IPOs roar back with Kailera and Alamar

This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset

2 Biotech Giants to Buy in 2026

Forget AI Stocks: This Biotech Could Cure What AI Can’t Touch

2 Under-the-Radar Biotech Stocks Set to Boom in 2026

Biotech rally mints huge profits for hedge funds

What One Fund’s Sale of Centessa Stock Signals About the Fast-Rising Biotech Company